key: cord-1047993-4vlv68e1 authors: Sharif, Fatima; Khan, Samreen; Junaid, Ayesha; Jahangir, Sehreen; Saeed, Maria; Ijaz, Maira; Ahmad, Imran Nazir; Kamran, Shawana title: Early hematological indicators of severe COVID‐19 disease in hospitalized patients: Data from a South Asian population date: 2021-04-09 journal: Int J Lab Hematol DOI: 10.1111/ijlh.13533 sha: a151a30453a34518aabef4200460f6949079d0de doc_id: 1047993 cord_uid: 4vlv68e1 INTRODUCTION: Outbreak of corona virus disease in 2019 (COVID‐19) has resulted in significant morbidity and mortality worldwide. Our aim is to document hematological parameters of patients with COVID‐19 during initial stage of diagnosis and to identify early hematological indicators of severe infection. MATERIALS AND METHODS: This retrospective study was conducted at Shifa International Hospital, Pakistan from April to November 2020. Patients hospitalized with COVID‐19, diagnosed on RT‐PCR and had a complete blood count (CBC) done within 48 hours of diagnosis were included. Data was analyzed using IBM(®) SPSS Statistics. RESULTS: A total of 425 patients were included in this study out of whom 272(64%) were males. The mean age was 55.61 ± 17.84 years. 95 patients (22.4%) had normal blood counts within 48 hours of COVID‐19 diagnosis. Cytopenias were seen in 193(45.4%) patients. There were 75(17.6%) mortalities during the study period. Chi‐square test showed that thrombocytopenia, lymphopenia and neutrophilic leucocytosis were significantly associated with mortality (P = .037, P < .001, P < .001 respectively) and need for ventilator (P = .009, P < .001, P < .001, respectively). Neutrophilia was also associated with development of Acute Respiratory Distress Syndrome (P < .001). On ROC analysis, Neutrophil‐to‐Lymphocyte Ratio yielded an area under the curve (AUC) of 0.693 and 0.660 for the outcomes mortality and need for ventilator, respectively. For a subset of 288 patients who had D‐dimer levels checked within 48 hours of COVID‐19 diagnosis, the AUC for mortality and ventilator need was 0.708 and 0.671, respectively. CONCLUSION: Hematological indices are vital indicators in the prognosis and risk stratification of COVID‐19 during initial stages of disease. The clinical manifestations of COVID-19 are diverse, ranging from asymptomatic carrier state to life threatening pneumonia. 5 Early identification and risk stratification of patients with COVID-19 is essential to facilitate timely isolation protocols and patient management. 6 Currently, many studies are investigating the hematological and chemical parameters in patients with COVID-19 in order to identify common patterns and biomarkers seen in this disease. 7, 8 The complete blood count (CBC) is one of the initial investigations ordered when a patient presents to the hospital with any symptoms. This is a quick, simple, and easily available test which offers valuable information about the patient's condition along with severity of signs and symptoms. Previously, the CBC has served as a useful marker in dengue virus infections, with presence of plasmacytoid lymphocytes and thrombocytopenia serving as indicators of diagnosis and severity of dengue infection. 9 Now, a variety of hematological manifestations of SARS-CoV-2 ranging from cytopenias to coagulopathy are also being discovered, which can be also used for disease prognostication in patients with Therefore, the aim of this study is to document the hematological parameters of patients with COVID-19 during the initial stage of diagnosis. We hope to identify the early hematological indicators of SARS-CoV-2 infection and their association with adverse outcomes in this population of South Asian patients hospitalized with COVID-19. This retrospective study was conducted at Shifa International Hospital (SIH), a 550 bed tertiary care hospital in Pakistan which is accredited by the Joint Commission International. The medical records of patients who were hospitalized with COVID-19 during the study period of April to November 2020 were assessed. We included those hospitalized patients in whom SARS-CoV-2 was detected by RT-PCR, whereas patients diagnosed with COVID-19 on radiological imaging alone were excluded. COVID-19 patients managed on an out-patient basis were also excluded from the study population. A standardized data collection form was developed to retrospectively retrieve relevant information from the medical records. Data were collected regarding patient demographics and laboratory parameters within 48 hours of PCR diagnosis of COVID-19. The outcome variables indicating disease severity were occurrence of all-cause in hospital mortality, need for mechanical ventilation, and length of hospital stay. We also identified those patients who developed Acute Respiratory Distress Syndrome (ARDS), defined according to Berlin criteria. 11 Hematological parameters were reported according to standardized reference ranges (quoted in the results section). The following definitions were used during interpretation of CBC: The neutrophil-to-lymphocyte ratio was determined by dividing the absolute neutrophil count by the absolute lymphocyte count. Normal NLR in healthy adults is up to 3.5, with higher values associated with infection and inflammation. 12 Lymphopenia: Lymphopenia was defined as an absolute lymphocyte count of less than 1000/µL. 13 Neutrophilic leucocytosis: Diagnosed as an absolute neutrophil count greater than 8000/µL. 14 Thrombocytopenia: Defined as platelet count of less than 150 000/µL. Data were analyzed using IBM ® SPSS Statistics Version 21. Mean ± standard deviation were calculated for normally distributed quantitative variables, median, and interquartile range were determined for skewed quantitative variables and frequencies and percentages were reported for qualitative data. 15 A total of 425 patients who were hospitalized with COVID-19 and Among the subset of patients in whom ARDS was identified, chi-square test showed that the occurrence of neutrophilia within the first 48 hours of COVID-19 diagnosis was the only hematological parameter significantly associated with development of ARDS (P < .001). Spearman's correlation showed that there was a significant association between NLR and length of hospital stay, however this association was weak (Spearman's ρ .237, P < .001). Figure 1 , along with their interpretation in Table 3 . COVID-19 could be a consequence of increased inflammatory response and cytokine storm resulting in secondary hemophagocytic lymphohistiocytosis. 18 Regarding thrombocytopenia, it is hypothesized that SARS-CoV-2 infection results in increased platelet destruction due to circulating autoantibodies and immune complexes. 19 Lung injury also leads to endothelial damage, platelet acti- Hematological indices including platelet count, absolute lymphocyte count, neutrophil count, NLR, and D-dimer play a valuable role in diagnosis, risk stratification, and prognosis of patients hospitalized with COVID-19 during early stages of infection. We would like to acknowledge the efforts of Ms Mehwish Rafique, biostatistician at Shifa International Hospital for her assistance during the data analysis of this study. The authors have no competing interests. Fatima Sharif: Study conception and design, data collection, data analysis and interpretation, and manuscript writing. Samreen Khan: Study conception and design, data collection, and manuscript writ- Data available on request from the authors. Fatima Sharif https://orcid.org/0000-0002-3366-9830 WHO declares COVID-19 a pandemic Laboratory diagnosis of COVID-19 Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2 Clinical features of covid-19 Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis Hematologic parameters in patients with COVID-19 infection Atypical lymphocyte count correlates with the severity of dengue infection Haematological manifestations of COVID-19: from cytopenia to coagulopathy Acute respiratory distress syndrome What is the normal value of the neutrophil-to-lymphocyte ratio? Absolute lymphocyte count is a prognostic marker in Covid-19: a retrospective cohort review Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients Univariate description and bivariate statistical inference: the first step delving into data COVID-19: review and hematologic impact Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19 Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases Mechanism of thrombocytopenia in COVID-19 patients The impact of COVID-19 disease on platelets and coagulation Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19 Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19 Routine blood tests as a potential diagnostic tool for COVID-19